CCDC134 facilitates T cell activation through the regulation of early T cell receptor signaling

Modulation of surface T cell antigen receptor (TCR) expression is crucial for proper T cell development and maintenance of mature T cell function at steady state and upon stimulation. We previously determined that CCDC134 (coiled-coil domain containing 134), a cytokine-like molecule that served as a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2023-05, Vol.14, p.1133111-1133111
Hauptverfasser: Zhang, Tianzhuo, Shi, Qianwen, Gu, Huining, Yu, Biaoyi, Yin, Sha, Ge, Qing, Mo, Xiaoning, Liu, Xiaofeng, Huang, Jing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Modulation of surface T cell antigen receptor (TCR) expression is crucial for proper T cell development and maintenance of mature T cell function at steady state and upon stimulation. We previously determined that CCDC134 (coiled-coil domain containing 134), a cytokine-like molecule that served as a potential member of the γc cytokine family, contributes to antitumor responses by augmenting CD8 T cell-mediated immunity. Here we show that T cell-specific deletion of decreased peripheral mature CD4 and CD8 T cells, which resulted in impaired T cell homeostasis. Moreover, -deficient T cells exhibited an attenuated response to TCR stimulation , showing lower activation and proliferative capacity. This was further reflected , rendering mice refractory to T cell-mediated inflammatory and antitumor responses. More importantly, CCDC134 is associated with TCR signaling components, including CD3ϵ, and attenuated TCR signaling in deficient T cells altered CD3ϵ ubiquitination and degradation. Taken together, these findings suggest a role for CCDC134 as a positive regulator of TCR-proximal signaling and provide insight into the cell-intrinsic functional consequences of deficiency in the attenuation of T cell-mediated inflammatory and antitumor responses.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1133111